Circular_0086414 induces SPARC like 1 (SPARCL1) production to inhibit esophageal cancer cell proliferation, invasion and glycolysis and induce cell apoptosis by sponging miR-1290

References

• Pennathur A, Gibson MK, Jobe BA, et al. Oesophageal carcinoma. Lancet. 2013;381(9864):400–412.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Gan H, Song W, et al. MicroRNA-145 promotes esophageal cancer cells proliferation and metastasis by targeting SMAD5. Scand J Gastroenterol. 2018;53(7):769–776.
   PubMed Web of Science ®Google Scholar
• Dubecz A, Gall I, Solymosi N, et al. Temporal trends in long-term survival and cure rates in esophageal cancer: a SEER database analysis. J Thorac Oncol. 2012;7(2):443–447.
   PubMed Web of Science ®Google Scholar
• Sun Y, Qiu L, Chen J, et al. Construction of circRNA-associated ceRNA network reveals novel biomarkers for esophageal cancer. Comput Math Methods Med. 2020;2020:7958362.
   PubMed Web of Science ®Google Scholar
• Kristensen LS, Andersen MS, Stagsted LVW, et al. The biogenesis, biology and characterization of circular RNAs. Nat Rev Genet. 2019;20(11):675–691.
   PubMed Web of Science ®Google Scholar
• Liu S, Li B, Li Y, et al. Circular RNA circ_0000228 promotes the malignancy of cervical cancer via microRNA-195-5p/ lysyl oxidase-like protein 2 axis. Bioengineered. 2021;12(1):4397–4406.
   PubMed Web of Science ®Google Scholar
• Wang J, Zhu W, Tao G, et al. Circular RNA circ-LRP6 facilitates Myc-driven tumorigenesis in esophageal squamous cell cancer. Bioengineered. 2020;11(1):932–938.
   PubMed Web of Science ®Google Scholar
• Li L, Zhang Z-T. Hsa_circ_0086414 might be a diagnostic biomarker of oral squamous cell carcinoma. Med Sci Monit. 2020;26:e919383–e919383.
   PubMed Web of Science ®Google Scholar
• Liu XX, Yang YE, Liu` X, et al. A two-circular RNA signature as a noninvasive diagnostic biomarker for lung adenocarcinoma. J Transl Med. 2019;17(1):50.
   PubMedGoogle Scholar
• Akagi T, Ito T, Kato M, et al. Chromosomal abnormalities and novel disease-related regions in progression from Barrett’s esophagus to esophageal adenocarcinoma. Int J Cancer. 2009;125(10):2349–2359.
   PubMed Web of Science ®Google Scholar
• Hauptman N, Glavac D. MicroRNAs and long non-coding RNAs: prospects in diagnostics and therapy of cancer. Radiol Oncol. 2013;47(4):311–318.
   PubMed Web of Science ®Google Scholar
• Zhang H, Liang F, Wang F, et al. miR-148-3p inhibits gastric cancer cell malignant phenotypes and chemotherapy resistance by targeting Bcl2. Bioengineered. 2021. doi:10.1080/21655979.2021.2005742.
   Google Scholar
• Wang W, Zhang Z, Li Y, et al. Down-regulated long non-coding RNA LHFPL3 antisense RNA 1 inhibits the radiotherapy resistance of nasopharyngeal carcinoma via modulating microRNA-143-5p/homeobox A6 axis. Bioengineered. 2022;13(3):5421–5433.
   PubMed Web of Science ®Google Scholar
• Bai M, Dong Y, Zhou C, et al. Effect of miR-196a inhibition on esophageal cancer growth in vitro. Anticancer Drugs. 2020;31(2):169–176.
   PubMed Web of Science ®Google Scholar
• Chen Y, Wang H, Zhu S, et al. miR-483-5p promotes esophageal cancer progression by targeting KCNQ1. Biochem Biophys Res Commun. 2020;531(4):615–621.
   PubMed Web of Science ®Google Scholar
• Xu J, Liu X, Liu X, et al. Long noncoding RNA KCNMB2-AS1 promotes the development of esophageal cancer by modulating the miR-3194-3p/PYGL axis. Bioengineered. 2021;12(1):6687–6702.
   PubMed Web of Science ®Google Scholar
• Li M, He XY, Zhang ZM, et al. MicroRNA-1290 promotes esophageal squamous cell carcinoma cell proliferation and metastasis. World J Gastroenterol. 2015;21(11):3245–3255.
   PubMed Web of Science ®Google Scholar
• Kulcheski FR, Christoff AP, Margis R. Circular RNAs are miRNA sponges and can be used as a new class of biomarker. J Biotechnol. 2016;238:42–51.
   PubMed Web of Science ®Google Scholar
• World medical association declaration of Helsinki: ethical principles for medical research involving human subjects. Jama. 2013;310(20):2191–2194.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25(4):402–408.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Lin W, Gao L, et al. Hsa_circ_0004370 promotes esophageal cancer progression through miR-1294/LASP1 pathway. Biosci Rep. 2019;39(5):BSR20182377.
   PubMedGoogle Scholar
• Pan G, Mao A, Liu J, et al. Circular RNA hsa_circ_0061825 (circ-TFF1) contributes to breast cancer progression through targeting miR-326/TFF1 signalling. Cell Prolif. 2020;53(2):e12720–e12720.
   PubMed Web of Science ®Google Scholar
• Song T, Xu A, Zhang Z, et al. CircRNA hsa_circRNA_101996 increases cervical cancer proliferation and invasion through activating TPX2 expression by restraining miR-8075. J Cell Physiol. 2019;234(8):14296–14305.
   PubMed Web of Science ®Google Scholar
• Shi P, Liu Y, Yang D, et al. CircRNA ZNF609 promotes the growth and metastasis of thyroid cancer in vivo and in vitro by downregulating miR-514a-5p. Bioengineered. 2022;13(2):4372–4384.
   PubMed Web of Science ®Google Scholar
• Chen J, Li X, Yang L, et al. CircASH2L promotes ovarian cancer tumorigenesis, angiogenesis, and lymphangiogenesis by regulating the miR-665/VEGFA axis as a competing endogenous RNA. Front Cell Dev Biol. 2020;8(595585). DOI:10.3389/fcell.2020.595585.
   Google Scholar
• Liu J-Q, Deng M, Xue -N-N, et al. lncRNA KLF3-AS1 suppresses cell migration and invasion in ESCC by impairing miR-185-5p-Targeted KLF3 inhibition. Mol Ther Nucleic Acids. 2020;20:231–241.
   PubMedGoogle Scholar
• Tan HZ, Lin WJ, Huang JQ, et al. Updated incidence rates and risk factors of esophageal cancer in Nan’ao Island, a coastal high-risk area in southern China. Dis Esophagus. 2017;30(1):1–7.
   Web of Science ®Google Scholar
• Wu J, Qi X, Liu L, et al. Emerging epigenetic regulation of circular RNAs in human cancer. Mol Ther Nucleic Acids. 2019;16:589–596.
   PubMedGoogle Scholar
• Lin H, Yuan J, Liang G, et al. Prognostic and diagnostic significance of circRNA expression in esophageal cancer: a meta-analysis. Gastroenterol Res Pract. 2020;2020:8437250.
   PubMed Web of Science ®Google Scholar
• Nord H, Hartmann C, Andersson R, et al. Characterization of novel and complex genomic aberrations in glioblastoma using a 32K BAC array. Neuro Oncol. 2009;11(6):803–818.
   PubMed Web of Science ®Google Scholar
• Beothe T, Zubakov D, Kovacs G. Homozygous losses detected by array comparative genomic hybridization in multiplex urothelial carcinomas of the bladder. Cancer Genet. 2015;208(9):434–440.
   PubMed Web of Science ®Google Scholar
• Brieher WM, Yap AS. Cadherin junctions and their cytoskeleton(s). Curr Opin Cell Biol. 2013;25(1):39–46.
   PubMed Web of Science ®Google Scholar
• Koppenol WH, Bounds PL, Dang CV. Otto Warburg’s contributions to current concepts of cancer metabolism. Nat Rev Cancer. 2011;11(5):325–337.
   PubMed Web of Science ®Google Scholar
• Panda AC. Circular RNAs act as miRNA sponges. Adv Exp Med Biol. 2018;1087:67–79.
   PubMed Web of Science ®Google Scholar
• Ma Q, Wang Y, Zhang H, et al. miR-1290 contributes to colorectal cancer cell proliferation by targeting INPP4B. Oncol Res. 2018;26(8):1167–1174.
   PubMed Web of Science ®Google Scholar
• Huang J, Shen M, Yan M, et al. Exosome-mediated transfer of miR-1290 promotes cell proliferation and invasion in gastric cancer via NKD1. Acta Biochim Biophys Sin (Shanghai). 2019;51(9):900–907.
   PubMed Web of Science ®Google Scholar
• Kim G, An HJ, Lee MJ, et al. Hsa-miR-1246 and hsa-miR-1290 are associated with stemness and invasiveness of non-small cell lung cancer. Lung Cancer. 2016;91:15–22.
   PubMed Web of Science ®Google Scholar
• Mao Y, Liu J, Zhang D, et al. MiR-1290 promotes cancer progression by targeting nuclear factor I/X(NFIX) in esophageal squamous cell carcinoma (ESCC). Biomed Pharmacother. 2015;76:82–93.
   PubMed Web of Science ®Google Scholar
• Sun H, Wang L, Zhao Q, et al. Diagnostic and prognostic value of serum miRNA-1290 in human esophageal squamous cell carcinoma. Cancer Biomark. 2019;25(4):381–387.
   PubMed Web of Science ®Google Scholar
• Isler SG, Schenk S, Bendik I, et al. Genomic organization and chromosomal mapping of SPARC-like 1, a gene down regulated in cancers. Int J Oncol. 2001;18(3):521–526.
   PubMed Web of Science ®Google Scholar
• Lau CP, Poon RT, Cheung ST, et al. SPARC and Hevin expression correlate with tumour angiogenesis in hepatocellular carcinoma. J Pathol. 2006;210(4):459–468.
   PubMed Web of Science ®Google Scholar
• Kos K, Wilding JP. SPARC: a key player in the pathologies associated with obesity and diabetes. Nat Rev Endocrinol. 2010;6(4):225–235.
   PubMed Web of Science ®Google Scholar
• Gagliardi F, Narayanan A, Gallotti AL, et al. Enhanced SPARCL1 expression in cancer stem cells improves preclinical modeling of glioblastoma by promoting both tumor infiltration and angiogenesis. Neurobiol Dis. 2020;134:104705.
   PubMed Web of Science ®Google Scholar
• Gong YB, Fan XH. MiR-539-3p promotes the progression of epithelial ovarian cancer by targeting SPARCL1. Eur Rev Med Pharmacol Sci. 2019;23(6):2366–2373.
   PubMed Web of Science ®Google Scholar
• Ye H, Wang WG, Cao J, et al. SPARCL1 suppresses cell migration and invasion in renal cell carcinoma. Mol Med Rep. 2017;16(5):7784–7790.
   PubMed Web of Science ®Google Scholar